SequelSEC

HeartSciences Inc. HSCS

Finance Services · CIK 0001468492 · Fiscal year ends 0430 · Bank

Revenue
$4.32K
Fiscal year ended 2026-04-30
Net income
-$9.14M
Fiscal year ended 2026-04-30
Total assets
$5.26M
Fiscal year ended 2026-04-30

Valuation, from the filing

Public float$10.40MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-10-31
Float per share$2.67Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2408.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity46.0×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-10-31, not today, and each multiple below it uses the figures for the fiscal year ending 2026-04-30 — the year that filing covered.

How this compares in its industry

Percentile among the Finance Services filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
FCF margin-172036.6%0th
R&D / revenue65733.1%100th
SBC / revenue30386.3%99th
Operating margin-194787.4%1th
Net margin-211666.5%2th
CapEx / revenue82.3%85th
Current ratio0.53x22th
Revenue YoY growth-0.7%34th
Gross margin59.1%62th

HeartSciences Inc. (HSCS) reported revenue of $4.32K and net income of -$9.14M for the fiscal year ended 2026-04-30. This page shows 5 annual periods of income statement, balance sheet and cash flow figures normalized from HeartSciences Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Finance Services.

Banks, brokers and insurers present a top line that is not comparable with an operating company’s revenue: it is reported net of interest expense, or as premiums earned, depending on the filer. The figures are the filer’s own and are traceable to the filing; the comparison across classes is what does not hold.

Income

HeartSciences Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-302025-04-302024-04-302023-04-302022-04-30
Revenue$4.32K$4.35K$18.60K$5.15K$14.37K
Cost of revenue$1.77K$1.88K$6.08K$2.80K$7.89K
Gross profit$2.55K$2.47K$12.52K$2.35K$6.48K
Operating income-$8.41M-$8.35M-$6.31M-$6.11M-$4.71M
Net income-$9.14M-$8.77M-$6.61M-$6.35M-$4.83M
Research & development$2.84M$4.39M$2.88M$2.46M$3.00M
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableshares 3.32M
Pretax incomeUnavailableUnavailableUnavailableUnavailableUnavailable
Income tax expense$0$0UnavailableUnavailableUnavailable
Diluted EPSUnavailable$-9.34$-18.74$-80.00$-1.45
Selling, general & administrative$5.58M$3.97M$3.44M$3.65M$1.71M
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

HeartSciences Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-302025-04-302024-04-302023-04-302022-04-30
Cash & equivalents$1.66M$1.10M$5.81M$1.66M$918.26K
Total assets$5.26M$4.22M$9.50M$3.29M$2.09M
Current assets$2.58M$2.17M$7.35M$2.70M$1.93M
Total liabilities$5.04M$4.02M$2.19M$3.06M$8.15M
Current liabilities$4.86M$3.70M$1.75M$1.83M$3.47M
Total equity incl. NCI$226.06K$205.17K$7.32M$230.56K-$6.06M
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailable
Inventory$655.63K$650.27K$629.18K$676.36K$674.14K
Accounts receivableUnavailable$4.35KUnavailableUnavailable$2.32K
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailableUnavailableUnavailable
Accounts payable$318.33K$318.66K$448.18K$631.37K$694.74K

Cash flow

HeartSciences Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-302025-04-302024-04-302023-04-302022-04-30
Operating cash flow-$7.43M-$7.41M-$6.07M-$5.77M-$3.64M
Capital expenditures$3.55K$3.16K$64.46K$18.31K$1.93K
Investing cash flow-$44.45K-$30.19K-$125.27K-$18.31K-$1.93K
Financing cash flow$8.03M$2.73M$10.34M$6.53M$3.84M
Net change in cash$558.72K-$4.71M$4.15M$742.21K$194.78K
Stock-based compensation$1.31M$249.88K$405.02K$248.31K$68.40K
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

HeartSciences Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-04-302025-04-302024-04-302023-04-302022-04-30
Free cash flow-$7.43M-$7.42M-$6.13M-$5.79M-$3.65M
Gross margin59.1%56.8%67.3%45.7%45.1%
Operating margin-194787.4%-192013.1%-33902.0%-118698.3%-32765.6%
FCF margin-172036.6%-170486.2%-32981.9%-112463.8%-25367.5%
SBC / revenue30386.3%5744.5%2177.6%4821.5%475.9%
Current ratio0.53x0.59x4.20x1.47x0.56x
Revenue YoY growth-0.7%-76.6%261.2%-64.2%Unavailable
Net margin-211666.5%-201499.5%-35511.9%-123384.3%-33592.6%
R&D / revenue65733.1%100830.0%15476.1%47783.8%20883.1%
CapEx / revenue82.3%72.6%346.5%355.5%13.4%
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HSCS in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-09-14View SEC filing
10-K · Filed 2026-07-23View SEC filing
10-Q · Filed 2026-03-16View SEC filing
10-Q · Filed 2025-12-15View SEC filing
10-Q · Filed 2025-09-11View SEC filing
10-K · Filed 2025-07-24View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.